TD Cowen analyst Dan Brennan lowered the firm’s price target on Thermo Fisher to $693 from $711 and keeps an Outperform rating on the shares. The analyst said concerns over weaker bioproduction tough comps and less room for upside to 2023 guidance weighed on shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TMO:
- Thermo Fisher price target lowered to $670 from $693 at Baird
- Thermo Fisher price target lowered to $610 from $625 at Barclays
- Thermo Fisher Scientific Earnings Update: Did it Beat Estimate Forecasts?
- Thermo Fisher backs FY23 adjusted EPS view $23.70, consensus $23.71
- Thermo Fisher Slides on Weak Q1
